Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer

Fig. 5

Subgroup analysis of risk scores in PCa patients with different Gleason scores and T stages. PCa patients with Gleason score ≥7 and T3 + T4 stage had higher risk scores than patients with Gleason score = 6 and T2 stage in the MSKCC cohort (A, B) and TCGA-PRAD (E, F) cohort. PCa patients with higher risk scores exhibited poorer RFS than patients with lower risk scores in PCa patients with a Gleason score ≥7 and T3 + T4 stage in the MSKCC cohort (C, D) and TCGA-PRAD (G, H) cohort

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us